PD-1 inhibition in patient derived tissue cultures of human gastric and gastroesophageal adenocarcinoma
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis in OncoImmunology
- Vol. 10 (1) , 1960729
Abstract
Emerging immunotherapies quest for better patient stratification in cancer treatment decisions. Moderate response rates of PD-1 inhibition in gastric and esophagogastric junction cancers urge for meaningful human model systems that allow for investigating immune responses ex vivo. Here, the standardized patient-derived tissue culture (PDTC) model was applied to investigate tumor response to the PD-1 inhibitor Nivolumab and the CD3/CD28 t-lymphocyte activator ImmunoCultTM. Resident t-lymphocytes, tumor proliferation and apoptosis, as well as bulk gene expression data were analyzed after 72 h of PD-1 inhibition either as monotherapy or combined with Oxaliplatin or ImmunoCultTM. Individual responses to PD-1 inhibition were found ex vivo and combination with chemotherapy or t-lymphocyte activation led to enhanced antitumoral effects in PDTCs. T-lymphocyte activation as well as the addition of pre-cultured peripheral blood mononuclear cells improved PDTC for studying t-lymphocyte and tumor cell communication. These data support the potential of PDTC to investigate immunotherapy ex vivo in gastric and esophagogastric junction cancer.Keywords
Funding Information
- Medical Faculty, University of Leipzig
This publication has 56 references indexed in Scilit:
- Three‐dimensional models of cancer for pharmacology and cancer cell biology: Capturing tumor complexity in vitro/ex vivoBiotechnology Journal, 2014
- Acquired and intrinsic resistance in cancer immunotherapyMolecular Oncology, 2014
- Heterogeneity in the Differentiation and Function of CD8+ T CellsArchivum Immunologiae et Therapiae Experimentalis, 2014
- Optimal chemotherapy for advanced gastric cancer: is there a global consensus?Gastric Cancer, 2013
- Phase II and Phase III attrition rates 2011–2012Nature Reviews Drug Discovery, 2013
- Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatmentsNeuro-Oncology, 2013
- The role of tumour–stromal interactions in modifying drug response: challenges and opportunitiesNature Reviews Drug Discovery, 2013
- Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III TrialJournal of Clinical Oncology, 2011
- Phase II failures: 2008–2010Nature Reviews Drug Discovery, 2011
- The tumor microenvironment and its role in promoting tumor growthOncogene, 2008